TY - JOUR
T1 - Hepatic FGF21 preserves thermoregulation and cardiovascular function during bacterial inflammation
AU - Huen, Sarah C.
AU - Wang, Andrew
AU - Feola, Kyle
AU - Desrouleaux, Reina
AU - Luan, Harding H.
AU - Hogg, Richard
AU - Zhang, Cuiling
AU - Zhang, Qing Jun
AU - Liu, Zhi Ping
AU - Medzhitov, Ruslan
N1 - Funding Information:
This study was supported by the Howard Hughes Medical Institute, Else Kröner Fresenius Foundation, the Blavatnik Family Foundation, and the National Institutes of Health (grants AI046688, AI089771, and CA157461). S.C. Huen was supported by the National Institutes of Health (grants K08DK110424 and R35GM137984) and the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant. A. Wang was supported by the National Institutes of Health (grants T32 AR07107-39 and K08AI128745). Plasma creatinine samples and invasive hemodynamic telemetric monitoring were performed through the George M. O’Brien Kidney Center at Yale (National Institutes of Health grant P30-DK079310). Preparation of the heart histology sections were processed by the UT Southwestern Histo Pathology Core via the George M. O’Brien Kidney Research Core Center at UT Southwestern Medical Center (National Institutes of Health grant P30-DK079328).
Publisher Copyright:
© 2021 Huen et al.
PY - 2021/8/18
Y1 - 2021/8/18
N2 - Sickness behaviors, including anorexia, are evolutionarily conserved responses to acute infections. Inflammation-induced anorexia causes dramatic metabolic changes, of which components critical to survival are unique depending on the type of inflammation. Glucose supplementation during the anorectic period induced by bacterial inflammation suppresses adaptive fasting metabolic pathways, including fibroblast growth factor 21 (FGF21), and decreases survival. Consistent with this observation, FGF21-deficient mice are more susceptible to mortality from endotoxemia and polybacterial peritonitis. Here, we report that increased circulating FGF21 during bacterial inflammation is hepatic derived and required for survival through the maintenance of thermogenesis, energy expenditure, and cardiac function. FGF21 signaling downstream of its obligate coreceptor, β-Klotho (KLB), is required in bacterial sepsis. However, FGF21 modulates thermogenesis and chronotropy independent of the adipose, forebrain, and hypothalamus, which are operative in cold adaptation, suggesting that in bacterial inflammation, either FGF21 signals through a novel, undescribed target tissue or concurrent signaling of multiple KLB-expressing tissues is required.
AB - Sickness behaviors, including anorexia, are evolutionarily conserved responses to acute infections. Inflammation-induced anorexia causes dramatic metabolic changes, of which components critical to survival are unique depending on the type of inflammation. Glucose supplementation during the anorectic period induced by bacterial inflammation suppresses adaptive fasting metabolic pathways, including fibroblast growth factor 21 (FGF21), and decreases survival. Consistent with this observation, FGF21-deficient mice are more susceptible to mortality from endotoxemia and polybacterial peritonitis. Here, we report that increased circulating FGF21 during bacterial inflammation is hepatic derived and required for survival through the maintenance of thermogenesis, energy expenditure, and cardiac function. FGF21 signaling downstream of its obligate coreceptor, β-Klotho (KLB), is required in bacterial sepsis. However, FGF21 modulates thermogenesis and chronotropy independent of the adipose, forebrain, and hypothalamus, which are operative in cold adaptation, suggesting that in bacterial inflammation, either FGF21 signals through a novel, undescribed target tissue or concurrent signaling of multiple KLB-expressing tissues is required.
UR - http://www.scopus.com/inward/record.url?scp=85114753425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114753425&partnerID=8YFLogxK
U2 - 10.1084/jem.20202151
DO - 10.1084/jem.20202151
M3 - Article
C2 - 34406362
AN - SCOPUS:85114753425
SN - 0022-1007
VL - 218
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 10
M1 - e20202151
ER -